A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

This study is ongoing, but not recruiting participants.

Study NCT00322569 Information provided by Cordis Corporation

First Received: May 4, 2006 Last Updated: April 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2012
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Publications:

Verheye,S et al. The GENESIS (Randomized Multi-center Study of the Pimecrolimus-eluting and Pimecrolimus/Paclitaxel-eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries)Trial. J Am Coll Cardiol Intv 2009;2:205-214

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Verheye S, Agostoni P, Dawkins KD, Dens J, Rutsch W, Carrie D, Schofer J, Lotan C, Dubois CL, Cohen SA, Fitzgerald PJ, Lansky AJ. The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) trial. JACC Cardiovasc Interv. 2009 Mar;2(3):205-14.